Needle Free Drug Delivery Devices Market
Global Needle-Free Drug Delivery devices Market Size, Share, and Trends Analysis Report by Technology (Inhaler Technology, Jet Injectors, Transdermal Patch Technology, and Other Technologies), and by Application (Pain Management, Insulin Delivery, Vaccine Delivery, Pediatric Injections, and Others) Forecast Period (2022-2028)
The global needle-free drug delivery devices market is anticipated to grow at a significant CAGR of 14.5% during the forecast period. Increasing the use of injections in healthcare facilities such as hospitals, clinics, and ambulatory surgical centers results in the spread of infectious diseases such as AIDS, Hepatitis B, and Hepatitis C. In addition, some incidences such as administering a tiny air bubble into a vein, or infections can take place that can cause risk to the patient’s life. Needles are often used repeatedly which is very hazardous as they can even transmit diseases to the human body when the same needles are used repeatedly or used incorrectly. A needle-free drug delivery system offers drugs to be delivered non-invasively into the patient’s body eliminating the risk of cross-contamination. Such benefits offered by needle freed drug delivery systems over conventional methods tend to spur the growth of the global needle freed drug delivery devices market.
Impact of COVID-19 Pandemic on Global Needle-Free Drug Delivery Devices Market
The COVID-19 pandemic led to shifts in drug use across the world. The needle-free injection system market has been positively impacted by the COVID-19 pandemic, as the need for mass vaccination among individuals. For instance, in April 2021, ISO stated that around 500 million people have already been vaccinated against COVID-19, and some 10 billion doses have been ordered. Moreover, it was estimated that some 8-10 billion syringes will be needed for the COVID-19 vaccine alone, which has surged the demand for the market over the forecast period.
Segmental Outlook
The global needle-free drug delivery devices market is segmented based on technology and application. Based on the technology, the market is segmented into inhaler technology, jet injectors, transdermal patch technology, and other technologies. Based on the application, the market is sub-segmented into pain management, insulin delivery, vaccine delivery, pediatric injections, and others. The above-mentioned segments can be customized as per the requirements. Among the technology segment, jet injectors are expected to fuel the needle-free drug delivery devices market due to their benefits over traditional drug transportation devices with needles. A jet injector uses high pressure to force a vaccine or other medication through an individual’s skin. Their speed made jet injectors very efficient, so many people could be vaccinated quickly.
Global Needle-Free Drug Delivery Devices Market Share by Application, 2021 (%)
The Insulin Delivery Segment is Expected to Hold a Prominent Share in the Global Needle-Free Drug Delivery Devices Market
Needle-free drug delivery systems are expected to have a prominent share in insulin delivery owing to the increasing incidence of diabetes coupled with increasing unhealthy lifestyle habits. According to the IDF Diabetes Atlas, 537 million adults (20-79 years) were living with diabetes in 2021. However, 541 million adults have Impaired Glucose Tolerance (IGT), which places them at high risk of type 2 diabetes. With the increasing prevalence of diabetes, the demand for insulin delivery devices increases. In addition, the introduction of technologically advanced products such as insulin pens and inhalable insulin is further expected to give a boost to the segmental growth of the market over the forecast period.
Regional Outlooks
The global needle-free drug delivery devices market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among all regions, the North American region is expected to propel the growth of the market over the forecast period, due to the high awareness of the benefits of needle-free drug delivery devices across the region.
Global Needle-Free Drug Delivery Devices Market Growth, by Region 2022-2028
The Asia-Pacific Region is Expected to be the Fastest-Growing Region in the Global Needle-Free Drug Delivery Devices Market
The Asia Pacific is expected to be the fastest-growing region mainly due to the rising prevalence of diabetes in emerging countries such as China and India. For instance, according to the International Diabetes Federation (IDF), as of 2021, the number of people with diabetes in India is the second-highest in the world, after China (141 million). A further 40 million adults in India have Impaired Glucose Tolerance (IGT), which places them at high risk of developing type-2 diabetes. This creates an opportunity for diabetes-controlling devices in the region. Such rapidly increasing figures for diabetes in India have widened the scope for innovative diabetic products. Additionally, increasing demand for self-administration as in the case of diabetes, and pain-free delivery of drugs have boosted the market.
Market Players Outlook
The major companies serving the global needle-free drug delivery devices market include GlaxoSmithKline PLC, Mika Medical Co., Novartis International AG, PharmaJet, Inc., Portal Instruments, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2020, LEO Pharma A/S and Portal Instruments collaborated and forged a license agreement to develop Portal’s needle-free drug delivery system for use in combination with LEO Pharma’s portfolio of investigational and approved medicines. Portal Instruments developed a needle-free jet injector platform to address the increasing need for patients to self-administer biologics without the need for needles. This simplifies administration, eliminates the need for “sharps containers” in the home, and reduces the time needed to perform self-injections.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global needle-free drug delivery devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Needle-Free Drug Delivery Devices Market
• Recovery Scenario of Global Needle-Free Drug Delivery Devices Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Segmentation
4.1. Global Needle-Free Drug Delivery Devices Market by Technology
4.1.1. Inhaler Technology
4.1.2. Jet Injectors
4.1.3. Transdermal Patch Technology
4.1.4. Other Technologies (Laser-Based Technology)
4.2. Global Needle-Free Drug Delivery Devices Market by Application
4.2.1. Pain Management
4.2.2. Insulin Delivery
4.2.3. Vaccine Delivery
4.2.4. Pediatric Injections
4.2.5. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 3M Co.
6.2. Akra Dermojet
6.3. Antares Pharma
6.4. Boehringer Ingelheim International GmbH
6.5. Crossject
6.6. Endo International PLC
6.7. Enesi Pharma Ltd.
6.8. Ferring International Center S.A.
6.9. GlaxoSmithKline PLC
6.10. Injex Pharma GmbH
6.11. Inovio Pharmaceuticals, Inc.
6.12. Mika Medical Co.
6.13. Novartis International AG
6.14. PharmaJet, Inc.
6.15. Portal Instruments, Inc.
6.16. ProSolus, Inc.
6.17. Pulse NeedleFree Systems, Inc.
6.18. Recipharm AB
6.19. Spirit Healthcare Ltd.
6.20. Zealand Pharma A/S
1. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
2. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY INHALER TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY JET INJECTORS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY TRANSDERMAL PATCH TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY OTHER TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
7. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR INSULIN DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR VACCINE DELIVERY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR PEDIATRIC INJECTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
13. NORTH AMERICAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
16. EUROPEAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
17. EUROPEAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
18. EUROPEAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
22. REST OF THE WORLD NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. REST OF THE WORLD NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
24. REST OF THE WORLD NEEDLE-FREE DRUG DELIVERY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET, 2022-2028 (%)
4. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
5. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY INHALER TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY JET INJECTORS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY TRANSDERMAL PATCH TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES BY OTHER TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR PAIN MANAGEMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR INSULIN DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR VACCINE DELIVERY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR PEDIATRIC INJECTIONS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. US NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
17. CANADA NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
18. UK NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
19. FRANCE NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
20. GERMANY NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
21. ITALY NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
22. SPAIN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF EUROPE NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
24. INDIA NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
25. CHINA NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
26. JAPAN NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
27. SOUTH KOREA NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
28. REST OF ASIA-PACIFIC NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF THE WORLD NEEDLE-FREE DRUG DELIVERY DEVICES MARKET SIZE, 2021-2028 ($ MILLION)
